Navigation Links
Medical Colleges, Confident of Meeting Standards Before 90-days deadline

The state governed medical colleges have not much to improve their standards, as stipulated by the Medical Council of India (MCI) //, which has given them a three month deadline to comply with the norms or face a risk of de-affiliation.

MCI is the authorized body that has the power to accord affiliation to medical colleges across the country, has issued a 90-day deadline for the three colleges, which is due to end in May.

A month has passed since the meeting, but Mahatma Gandhi Memorial Medical College, Hospital (Jamshedpur), Patliputra Medical College and Hospital (Dhanbad) and Rajendra Institute of Medical Sciences (Ranchi) have not done much to comply with guidelines.

Gajendra Thakur, a member of the executive body of MCI and president of the Bihar chapter of the Indian Medical Association (IMA). Thakur said: “The de-affiliation was deferred for 90 days on condition that the institutions improve the facilities to ensure bed occupancy in their hospitals.”

The area that need to be spruced up range from an inoperative ICU, CT scan facility, or even for that matter availability of teaching staff , which continues to haunt the medical colleges in question. Despite funds being provided to the hospitals to facilitate the requirements, precious little has bee done.

Jagannath Prasad, former acting director of RIMS and head of department, anaesthesia, said, “Steps are being taken to ensure that the deficiencies pointed out are rectified at the earliest.”

The colleges are hopeful of complying with the stipulations before the deadline is over.


'"/>




Page: 1

Related medicine news :

1. Indian Nationals with Foreign Medical Degrees can now practice in India
2. Meditation Works Medically
3. Sleep Disorders Could Indicate Other Medical Problems
4. Being Obese Increases Ones Risk Of A wrong Diagnosis During Medical Imaging
5. Hypnosis Found To Reduce Stress In Children During Medical Procedures
6. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
7. Ayurvedic Therapies Cashing In On Medical Tourism
8. Prevention And Timely Medical Care Can Help With Bug Bites
9. Government Organisation Proposes Strict Guidelines For SubStandard Medical Devices
10. Grant of $7 million for Orissa Medical College from Japan
11. Indian Hospitals – A Destination For Quality Medical Care
Post Your Comments:
(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...
(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...
(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...
(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...
Breaking Medicine News(10 mins):Health News:Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use 2Health News:Medicare Advantage Plans Struggle to Comply With New Federal Law 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 3Health News:Longs Drug Stores Corporation Reports Second Quarter Results 4Health News:Longs Drug Stores Corporation Reports Second Quarter Results 5Health News:Longs Drug Stores Corporation Reports Second Quarter Results 6Health News:Longs Drug Stores Corporation Reports Second Quarter Results 7Health News:Longs Drug Stores Corporation Reports Second Quarter Results 8Health News:Longs Drug Stores Corporation Reports Second Quarter Results 9Health News:Longs Drug Stores Corporation Reports Second Quarter Results 10Health News:Longs Drug Stores Corporation Reports Second Quarter Results 11Health News:Longs Drug Stores Corporation Reports Second Quarter Results 12Health News:Longs Drug Stores Corporation Reports Second Quarter Results 13Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3
...bstetrical anesthesia, whether provided by Certifi...esiologists, is extremely safe//. There is no diff...RNAs compared with those that use only anesthesiol...e study, titled "Anesthesia Staffing and Anestheti...
... new method in ultrasound known as "eSie Touch Ela...Solutions at the ECR 2007 (European Congress of Ra...t this new method, which is an adjunct to regular ...nically relevant differentiation of benign and mal...
...ew research from the University of North Carolina ...wo proteins that may help protect against skin can...line edition of the journal Molecular and Cellular..., named Timeless and Tipin, form a complex that re...
...hubaneswar: Scientists in Orissa have developed a ...others and is bacteria resistant.// A team of scie...ect three years ago to develop a variety of fish t...cterial disease affecting hatcheries in India, Pra...
Other Medicine News:Health News:Obstetrical Anesthesia Equally Safe When Provided by CRNAs or Anesthesiologists 2Health News:eSie Touch Elasticity Imaging, and a Promise of Avoiding Breast Biopsies 2Health News:Researchers Discover Proteins That Protect Against Skin Cancer 2Health News:Scientists Develop Bacteria-resistant Fish 2
(Date:8/17/2008)...Aug. 17 /Xinhua-- Pharmaxis... first pivotal Phase 3,clinical trial of Bronchito...ed enrolment., The first efficacy data from the t...half of 2009. The trial commenced its dosing phase...rget of 250 subjects in June,2008 and closed today...
(Date:8/14/2008)...g. 14 /- Pharmasset, Inc.,(...ompany committed to,discovering, developing and co...s, reported unaudited financial results for the th... reported a net loss attributable to,common stockh....69 for the,quarter ended June 30, 2008, as compar...
(Date:8/14/2008)...pment to begin in late 2008 or in early 2009 -, S...-- Nuvelo, Inc.,(Nasdaq: NUVO ) today announced p... trial of NU172, demonstrating that the direct thr...ticoagulation with a rapid,return toward baseline ...rofile., "NU172 has the potential to address many...
(Date:8/13/2008)...hid Pharma partners with Diakron, MORRIS PLAINS, ...als,Inc. announced today the signing of an exclus...oral anticoagulant drug candidate discovered and,d...& Co. Inc. Under the,terms of the agreement, Diakr...proved, market and distribute the compound worldwi...
Breaking Medicine Technology:Bronchitol Phase 3 Cystic Fibrosis Trial Completes Recruitment 2Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 2Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 3Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 4Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 5Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 6Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 7Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 8Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 9Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 2Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 3Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 4Diakron Licenses Anticoagulant Drug Candidate from Merck & Co., Inc. 2America On the Move and More Than 1 500 YMCAs Kick Off Steptember 2007 451 1America On the Move and More Than 1 500 YMCAs Kick Off Steptember 2007 451 2America On the Move and More Than 1 500 YMCAs Kick Off Steptember 2007 451 3America On the Move and More Than 1 500 YMCAs Kick Off Steptember 2007 451 4WuXi PharmaTech Schedules 2007 Second Quarter Earnings Release on Thursday September 6 2007 337 1WuXi PharmaTech Schedules 2007 Second Quarter Earnings Release on Thursday September 6 2007 337 2WuXi PharmaTech Schedules 2007 Second Quarter Earnings Release on Thursday September 6 2007 337 3Nanotechnology 3A Whats that 3F 244 1Nanotechnology 3A Whats that 3F 244 2The aye ayes have it 3A The preservation of color vision in a creature of the night 445 1The aye ayes have it 3A The preservation of color vision in a creature of the night 445 2The aye ayes have it 3A The preservation of color vision in a creature of the night 445 3
...SS WIRE)--Jun 25, 2007 - Gilead,Sciences, Inc. (Na... III clinical trial evaluating the company,s once-...l fumarate or tenofovir,DF) 300 mg as a potential ...ction, met its primary efficacy endpoint. The data... once-daily antiviral,drug Hepsera(R) (adefovir di...
... WIRE)--Jun 25, 2007 - Affymax, Inc.,(Nasdaq:AFFY)...trial results for Hematide(TM) were presented at t...held in Barcelona, Spain by Iain C.,Macdougall, M....ndon. Dr. Macdougall,s poster included data in pre...ive, non-dialysis patients which,demonstrated that...
Other Medicine Technology:Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 2Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 3Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 4Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 5Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 6Affymax Reports Phase 2 Clinical Dose Ranging Results of,Once-Per-Month Hematide for the Treatment of Anemia 2Affymax Reports Phase 2 Clinical Dose Ranging Results of,Once-Per-Month Hematide for the Treatment of Anemia 3
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
Medicine Products: